Abstract
AbstractTuberculosis (TB) and Human Immunodeficiency virus (HIV) coinfection continues to be a very serious health concern globally. Even though TB is treatable, it remains among the leading cause of death especially among HIV‐infected individuals. Although the emergence of antiretroviral therapy (ART) has positively impacted the treatment of HIV, it is a major risk factor for developing active TB disease. The treatment of HIV and TB coinfection is associated with many challenges, one of which is the requirement of treatment with multiple medications for an extended period which is faced by all infected individuals across every age group, however, some of the challenges are peculiar to a specific age range. This review provides a comprehensive analysis of HIV and TB co‐infection among persons within different age brackets and the characteristics of both diseases, their current treatment guidelines, the challenges they pose, and their impact on global health are examined and reported herein.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
